Taiyen Biotech CoTPE:1737 83 Days Payable is 44.04 as of Dec. 2025, which is 37% above its 10-year median of 32.19. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,880 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 56.7% on this metric.
The historical rank and industry rank for Taiyen Biotech Co's Days Payable or its related term are showing as below:
TPE:1737'
s Days Payable Range Over the Past 10 Years
Min: 8.33 Med: 32.19 Max: 57.18
Current: 50.43
During the past 13 years, Taiyen Biotech Co's highest Days Payable was 57.18. The lowest was 8.33. And the median was 32.19.
TPE:1737's Days Payable is ranked better than 56.7% of 1880
companies
in the Consumer Packaged Goods industry
Industry Median: 44.05
vs TPE:1737: 50.43
Taiyen Biotech Co's Days Payable
declined
from Dec. 2024 (57.46) to Dec. 2025 (44.04).
It may suggest that Taiyen Biotech Coaccelerated paying its suppliers.
Taiyen Biotech Co Days Payable Related Terms
Taiyen Biotech Co Days Payable Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Taiyen Biotech Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Taiyen Biotech Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiyen Biotech Co (TPE:1737) has a Days Payable of 44.04 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Taiyen Biotech Co and its competitors. This is 37% above median its historical median of 32.19. Over the past decade, Taiyen Biotech Co's Days Payable has ranged from 8.33 to 57.18. According to the industry distribution chart, Taiyen Biotech Co ranks #814 out of 1880 companies in the Consumer Packaged Goods industry, placing it in the top 43.3%.
Is Taiyen Biotech Co's Days Payable too high?
Taiyen Biotech Co's current Days Payable of 44.04 is 37% above median its 10-year median of 32.19. Over the past 10 years, this metric has ranged from a low of 8.33 to a high of 57.18. The Consumer Packaged Goods industry median Days Payable is 44.05. Taiyen Biotech Co's value of 44.04 is 0% below this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #814 out of 1880 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Days Payable compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #814 out of 1880 companies for Days Payable. This puts Taiyen Biotech Co in the upper half of its industry. The industry median Days Payable is 44.05. Taiyen Biotech Co's value of 44.04 is 0% below this benchmark. Historically, Taiyen Biotech Co's own Days Payable has ranged from 8.33 to 57.18 over the past decade. While the company's 10-year median is 32.19 vs. the industry median of 44.05, Taiyen Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.05, based on 1,880 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current Days Payable of 44.04 is 0% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current Days Payable is 44.04, which is 37% above median its own 10-year median of 32.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current Days Payable is 44.04, which is 37% above median its 10-year median of 32.19 and 0% below the Consumer Packaged Goods industry median of 44.05. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Days Payable is 44.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
Days Payable: 44.04 (37% above median its 10-year median of 32.19)
GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
Industry Position: 0% below the Consumer Packaged Goods median (#814 of 1880)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
